---
title: Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma
date: '2023-08-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37547266/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230807180848&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: This study provides first indication that the combination
  of trofosfamide plus etoposide is safe in adult glioblastoma patients. The observed
  survival outcomes might suggest potential beneficial effects. Our data provide a
  reasonable rationale for follow-up of a larger cohort in a prospective ...'
disable_comments: true
---
CONCLUSIONS: This study provides first indication that the combination of trofosfamide plus etoposide is safe in adult glioblastoma patients. The observed survival outcomes might suggest potential beneficial effects. Our data provide a reasonable rationale for follow-up of a larger cohort in a prospective ...